lactic acid has been researched along with Myocarditis in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the multivariate Cox model analysis, cardiac arrest prior to ECMO initiation (adjusted HR 2." | 1.91 | Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China. ( Chen, C; Du, Z; Guo, F; Hao, T; Hou, X; Huang, Y; Jiang, Y; Li, C; Liu, L; Liu, S; Pan, C; Qiu, H; Wu, C; Xie, H; Xie, J; Yang, Y, 2023) |
| "Sixteen children and adolescents with type 1 diabetes (T1D) had blood samples obtained, 6-12 hours into treatment, at three weeks and three months post start of treatment." | 1.56 | Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis ( Artlett, CM; Blum, J; Hoffman, WH; Ikeda, T; Ishikawa, T; Tani, N, 2020) |
| "Myocarditis is an inflammatory disease of the myocardium with a wide range of clinical presentations, from vague flu-like symptoms to rapidly progressive heart failure." | 1.36 | Myocarditis masquerading as a ST elevation myocardial infarction (STEMI). ( Shah, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, T | 1 |
| Jiang, Y | 1 |
| Wu, C | 1 |
| Li, C | 1 |
| Chen, C | 1 |
| Xie, J | 1 |
| Pan, C | 1 |
| Guo, F | 1 |
| Huang, Y | 1 |
| Liu, L | 1 |
| Xie, H | 1 |
| Du, Z | 1 |
| Hou, X | 1 |
| Liu, S | 1 |
| Yang, Y | 1 |
| Qiu, H | 1 |
| Hoffman, WH | 1 |
| Ishikawa, T | 1 |
| Blum, J | 1 |
| Tani, N | 1 |
| Ikeda, T | 1 |
| Artlett, CM | 1 |
| Yang, L | 1 |
| Ye, L | 1 |
| Fan, Y | 1 |
| He, W | 1 |
| Zong, Q | 1 |
| Zhao, W | 1 |
| Lin, R | 1 |
| Nakano, Y | 1 |
| Matoba, T | 1 |
| Tokutome, M | 1 |
| Funamoto, D | 1 |
| Katsuki, S | 1 |
| Ikeda, G | 1 |
| Nagaoka, K | 1 |
| Ishikita, A | 1 |
| Nakano, K | 1 |
| Koga, J | 1 |
| Sunagawa, K | 1 |
| Egashira, K | 1 |
| Madea, B | 1 |
| Shah, A | 1 |
| Teele, SA | 1 |
| Allan, CK | 1 |
| Laussen, PC | 1 |
| Newburger, JW | 1 |
| Gauvreau, K | 1 |
| Thiagarajan, RR | 1 |
1 review available for lactic acid and Myocarditis
| Article | Year |
|---|---|
Sudden death, especially in infancy--improvement of diagnoses by biochemistry, immunohistochemistry and molecular pathology.
Topics: Adult; Blood Chemical Analysis; Child; Death, Sudden; Diabetes Mellitus, Type 1; DNA, Viral; Forensi | 2009 |
6 other studies available for lactic acid and Myocarditis
| Article | Year |
|---|---|
Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China.
Topics: Adult; Extracorporeal Membrane Oxygenation; Heart Arrest; Humans; Lactic Acid; Male; Myocarditis; Re | 2023 |
Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
Topics: Adolescent; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glycation End Products, | 2020 |
Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
Topics: Child; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Heart Defects, Congenital; Hos | 2019 |
Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
Topics: Administration, Intravenous; Animals; Biphenyl Compounds; Cardiotonic Agents; Disease Models, Animal | 2016 |
Myocarditis masquerading as a ST elevation myocardial infarction (STEMI).
Topics: Cardiac Catheterization; Creatine Kinase; Diagnosis, Differential; Electrocardiography; Fatal Outcom | 2010 |
Management and outcomes in pediatric patients presenting with acute fulminant myocarditis.
Topics: Acute Disease; Adolescent; Aspartate Aminotransferases; Child; Child, Preschool; Creatinine; Extraco | 2011 |